These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Immunodepressors in ophthalmology]. Bonnet M Annee Ther Clin Ophtalmol; 1971; 22():117-55. PubMed ID: 4356770 [No Abstract] [Full Text] [Related]
23. Current methods of therapy in multiple sclerosis. Sibley WA Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377 [No Abstract] [Full Text] [Related]
24. The evidence justifying immunosuppression therapy in multiple sclerosis. Mertin J Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967 [No Abstract] [Full Text] [Related]
25. [Glial migration inhibition test in multiple sclerosis patients and its changes during treatment with immunosuppressants]. Kogan OG; Kanchurin AKh; Kuznetsova OV; Brusina LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1798-1802. PubMed ID: 7340320 [TBL] [Abstract][Full Text] [Related]
26. Proceedings: Intensive immunosuppression in multiple sclerosis. Lance EM; Abbosh J; Kremer M; Jones V; Knight S; Medawar P Neurology; 1975 May; 25(5):491. PubMed ID: 1169713 [No Abstract] [Full Text] [Related]
27. [Abnormalities in the immune system of MS patients and possibilities of immunological treatment]. Salonen R; Ilonen J Duodecim; 1992; 108(1):82-92. PubMed ID: 1365988 [No Abstract] [Full Text] [Related]
29. From etiology and pathogenesis to therapy of multiple sclerosis. Cazzullo CL Boll Ist Sieroter Milan; 1978 Jan; 56(6):622-33. PubMed ID: 580220 [TBL] [Abstract][Full Text] [Related]
30. [Therapy of multiple sclerosis]. Kesselring J Schweiz Med Wochenschr; 1984 Sep; 114(35):1186-90. PubMed ID: 6091263 [TBL] [Abstract][Full Text] [Related]
31. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)]. Frick E; Angstwurm H; Strauss G MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823 [No Abstract] [Full Text] [Related]
32. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Stuart WH Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719 [TBL] [Abstract][Full Text] [Related]
33. [Guidelines for drug treatment of multiple sclerosis]. Kollegger H; Vass K; Marschall I; Koch G; Deecke L Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677 [TBL] [Abstract][Full Text] [Related]
34. [Multiple sclerosis--current status of therapy]. Reichel D; Kölmel HW Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682 [TBL] [Abstract][Full Text] [Related]
35. [Review of the therapy of multiple sclerosis]. De Rosa A; Puccini A; De Martino V Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734 [No Abstract] [Full Text] [Related]
36. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)]. Frick E; Angstwurm H; Blomer R; Strauss G MMW Munch Med Wochenschr; 1977 Sep; 119(35):1111-4. PubMed ID: 408666 [TBL] [Abstract][Full Text] [Related]
37. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease. Hafler DA; Weiner HL Chem Immunol; 1995; 60():126-49. PubMed ID: 7857525 [No Abstract] [Full Text] [Related]
38. [Modern views on the treatment of multiple sclerosis]. Sieniarski A Wiad Lek; 1974 Feb; 27(4):337-40. PubMed ID: 4360561 [No Abstract] [Full Text] [Related]
39. [Somatic and psychosocial therapy concepts in multiple sclerosis (I)]. Busse O; Kronsbein HJ Med Welt; 1981 Apr; 32(17):641-4 contd. PubMed ID: 7012537 [No Abstract] [Full Text] [Related]
40. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures. Karussis D; Slavin S J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]